The inspectors of the China Securities Regulatory Commission revealed yesterday (14th) that the inspectors called Huang Xiaoming during the case handling, and Huang Xiaoming also co-operated to find time to meet with the investigators for three hours.
According to Securities Times.com, inspectors said that because Huang Xiaoming is usually busy, his mother has been operating his account, and the existing evidence does not prove that he participated in or knew about stock manipulation, so he will not be held accountable. Earlier report: It is rumored that Huang Xiaoming's six accounts once organized a group to operate longevity organisms
The China Securities Regulatory Commission issued a market entry prohibition notice on August 10, accusing Gao Yong, a partner of Beijing Moat Investment Development Center, of controlling 16 accounts to manipulate stock prices, without fines and a total amount of 1.8 billion yuan (RMB, SGD 360 million).), and take measures to prohibit them from entering the securities market for life.
According to Sina Finance, among the 16 accounts, several accounts have been grouped into the top ten tradable shareholders of Longevity Biotech, including six accounts including Huang Xiaoming. At that time, Changsheng Biotech had not backdoored Huanghai Machinery. Huang Xiaoming issued a statement late at night: never participated in any stock manipulation
Famous Chinese actor Huang Xiaoming issued a statement on Weibo in the early hours of the 15th regarding Huang Xiaoming's involvement in the 1.8 billion stock manipulation case, Huang Xiaoming's group manipulation of Changsheng Pharmaceutical and other news reports, saying that the relevant reports were not true.
Huang Xiaoming said that after opening his stock account, his mother managed it on his behalf, and his mother entrusted the account to Lu Mou for financial management, and through Lu Mou's introduction, he entrusted Gao Yong to manage it. Gao Yong's account group engaged in the transactions involved in the case.A punishment decision has been made on the Gao Yong case.
Huang Xiaoming said that he has never participated in any stock manipulation and has nothing to do with Changsheng Biotech. The news that Huang Xiaoming organized a group to control Changsheng Pharmaceutical is a rumor.This incident was caused by careless financial management.
